NEW
Font size
WorksheetsElvioza CRVO JOURNAL
Total questions: 10
Worksheet time: 5mins
What is the best to assess macular edema?
OCT angiography
Fundus photography
SD-OCT
Fluorescein angiography
What is most common anterior complication of CRVO?
Neovascular glaucoma
Vitreous hemorrhage
Retinal traction
Macular edema
What is not the pathogenesis of Retinal Venous Occlusion?
Endothelial injury
Presence of anti-VEGF
Venous stasis
Hypercoagulability
Which of the following best describes the mechanism of action of Bevacizumab (Avastin) when used in intravitreal injections for Central Retinal Vein Occlusion (CRVO)?
It reduces intraocular pressure
It promotes retinal vascular regeneration
It inhibits VEGF (Vascular Endothelial Growth Factor) and reduces abnormal blood vessel growth
It directly repairs damaged retinal tissue
Which of the following is a primary goal of treatment for macular edema in CRVO?
Increasing intraocular pressure
Inducing retinal hemorrhages
Reducing inflammation in the optic nerve
Decreasing macular edema and improving visual acuity
What is a common cause of vision impairment in patients with Central Retinal Vein Occlusion (CRVO)?
Optic nerve damage
Macular edema
Retinal hemorrhages
Vitreous detachment
What is the primary difference between Pro Re Nata (PRN) and Treat and Extend (T&E) regimens for intravitreal injections in retinal diseases?
PRN involves injections at fixed intervals, while T&E relies on monitoring for disease activity
PRN involves extending the treatment intervals over time, while T&E relies on a fixed injection schedule
PRN is a proactive approach, while T&E is a reactive approach to treatment
PRN and T&E are two different names for the same treatment approach
How should patients be monitored during Bevacizumab treatment for CRVO?
Monthly eye exams with visual acuity testing
Annual blood tests
Quarterly dental check-ups
Weekly weight measurements
How often is Bevacizumab typically administered in the initial phase of CRVO treatment?
Every month
Every 3 months
Every 6 months
Once a year
In CRVO management, Bevacizumab is often used as an off-label treatment. What does "off-label" mean in this context?
It is used for a different medical condition than its FDA-approved indication
It is used without any medical supervision
It is used exclusively for pediatric patients
It is used as a first-line treatment
